In a patient with myasthenia gravis who is allergic to ciprofloxacin and amoxicillin and has a superficial 2‑cm lower‑leg wound infected with Pseudomonas aeruginosa, what oral treatment options can be used to avoid intravenous antibiotics?

Oral Treatment for Pseudomonas aeruginosa Wound Infection in MG Patient

Given your patient's myasthenia gravis and allergies to both ciprofloxacin and amoxicillin, the safest oral option for this superficial Pseudomonas aeruginosa wound infection is levofloxacin 750 mg daily, though this carries a small but real risk of MG exacerbation that requires close monitoring.

Critical Safety Considerations in MG

Antibiotics That Worsen MG

Your patient's medication allergies actually protect against two problematic agents:

• Fluoroquinolones (including ciprofloxacin and levofloxacin) can trigger MG exacerbations through neuromuscular blockade 1, 2
• Amoxicillin/penicillins have documented cases of acute MG worsening, though traditionally considered "safe" 3

The actual risk data shows fluoroquinolone-associated MG exacerbation occurs in 1.6-2.4% of exposures, with most events occurring within 1 day of starting treatment 2. Importantly, 30% of these exacerbations progress to myasthenic crisis requiring ventilatory support, and 5% result in death 1.

Practical Treatment Algorithm

Step 1: Assess Wound Severity

For a superficial 2-cm wound, you have more flexibility than with deep tissue infection. The guidelines don't specifically address Pseudomonas in superficial wounds, focusing instead on typical skin flora 4.

Step 2: Choose Oral Antibiotic

Primary recommendation: Levofloxacin 750 mg daily 4

Rationale:

• Ciprofloxacin is FDA-approved for Pseudomonas skin infections 5, but your patient is allergic
• Levofloxacin has equivalent Pseudomonas coverage 4
• While fluoroquinolones carry MG risk, levofloxacin showed only 1.6% exacerbation rate in the largest study 2
• No other oral agent reliably covers Pseudomonas aeruginosa

Alternative if fluoroquinolones absolutely contraindicated:

• Sulfamethoxazole-trimethoprim (SMX-TMP) 160-800 mg twice daily 4
  • Has "good activity against aerobes" per IDSA guidelines
  • However, resistance rates in superficial Pseudomonas infections can reach 31.9% 6
  • Consider only if local susceptibility data supports use

Step 3: Implement MG-Specific Monitoring

If prescribing levofloxacin, establish this safety protocol:

Before starting:

• Document baseline MG symptoms (ptosis, diplopia, dysphagia, limb weakness)
• Ensure patient has emergency contact information
• Consider baseline respiratory function if generalized MG

During treatment (especially first 24-48 hours):

• Daily phone check-ins for new/worsening weakness, breathing difficulty, swallowing problems
• Instruct patient to report immediately: dyspnea, dysphagia, diplopia, generalized weakness 1
• Have low threshold for ED evaluation if symptoms emerge

Risk factors for higher exacerbation risk:

• Recent MG hospitalization or ED visit (within 6 months) 2
• Female sex 2
• Diabetes 2

Step 4: Optimize Local Wound Care

Aggressive local management may reduce systemic antibiotic need:

• Copious irrigation and debridement 4
• Daily wound inspection and cleaning
• Consider topical antimicrobials (though evidence limited for Pseudomonas)

When IV Antibiotics Are Unavoidable

If the patient develops signs of deeper infection (cellulitis extending >2 cm, systemic symptoms, lymphangitis), oral therapy becomes inadequate regardless of MG concerns.

IV options that avoid fluoroquinolones and beta-lactams:

• Aminoglycosides (tobramycin, amikacin) - though resistance rates can reach 77-89% 6
• Polymyxin B - only 21.5% resistance in superficial infections 6
• Carbapenems (meropenem, imipenem) - only 2-3% resistance 6, but these are beta-lactams and cross-reactivity with amoxicillin allergy must be assessed

Critical Pitfalls to Avoid

1. Don't assume penicillin allergy = all beta-lactam allergy: If the amoxicillin "allergy" was actually just GI upset or rash without anaphylaxis, carbapenems may be safe after allergy evaluation

2. Don't ignore the infection: Untreated Pseudomonas can progress rapidly. The MG exacerbation risk from fluoroquinolones (1.6%) must be weighed against infection progression risk

3. Don't forget that infection itself worsens MG: The underlying infection is a common confounder in 88% of antibiotic-associated MG exacerbations 2. Treating the infection may actually improve MG control

4. Don't use macrolides: Azithromycin has no Pseudomonas coverage and also carries MG exacerbation risk 7, 2

Bottom Line Decision

For this specific scenario—superficial wound, documented Pseudomonas, MG with cipro/amoxicillin allergies—prescribe levofloxacin 750 mg daily with intensive MG monitoring for the first 48 hours. The 1.6% exacerbation risk is acceptable given lack of other oral options and the need to treat documented Pseudomonas infection. If MG symptoms worsen or the wound doesn't improve within 48-72 hours, transition to IV therapy with infectious disease and neurology consultation.